Clinically validated, AI-powered software for personalized screening and early detection of breast cancer.
2,000+
5,600+
“Volpara gives us confidence that we did the best possible job for our patients.”
– Deborah Hamel, Quality Assurance Manager, Derry Imaging
16.5 m+
“Knowing precisely how dense my breasts are gave me a clear path for screening.”
– Patient, Reno Diagnostic Centers
100 m+
“Every image we evaluate helps us evolve and improve our software, creating a path toward a healthier future.”
– Lester Litchfield, Head of Data Science, Volpara Health
Trusted by Healthcare Leaders
A clearer picture
AI has all the makings to be the tool healthcare providers need to reshape and improve patients outcomes and the patient experience at large. Volpara Health is one of the companies at the forefront of that development, with a specific focus on early breast cancer detection and prevention. Volpara’s offerings were featured in a profile by Microsoft Unlocked.
Get ready for 2024
January 1, 2024
New NAPBC Standards
The new NAPBC Standards Manual (2024) is a shift to more personalized care delivery with greater use of risk assessment and preventative protocols.
September 10, 2024
New FDA Density Rule
The Food & Drug Administration has updated the Mammography Quality Standards Act (MQSA) to make patient breast density notification a federal requirement.
